The evidence base for chronic nutrition management in UCDs is largely observational and supports individualized, dynamic nutrition prescriptions across the lifespan. Protein and energy intake are generally based on age-appropriate reference standards and adjusted according to disease severity, growth, clinical status, and biochemical monitoring, with the primary goals of supporting growth, preventing catabolism, and maintaining metabolic stability. Most individuals tolerate total protein intakes near or slightly below recommendations for healthy populations, whereas severe phenotypes often require greater degree of protein restriction.
Essential amino acid (EAA)-based medical foods are widely used, especially in arginase deficiency and other severe phenotypes, to support essential amino acid adequacy while limiting nitrogen load. Adequate energy intake is consistently emphasized to achieve a protein-sparing effect and help prevent metabolic instability. Enteral tube feeding is also a useful strategy to ensure reliable nutrient delivery and support growth, particularly in individuals with feeding difficulties or severe disease.
Evidence describing human milk feeding in infants with UCDs is limited but suggests that, when closely monitored and incorporated into structured feeding regimens, human milk may be safely used in selected cases. Ongoing uncertainty regarding exclusive, on-demand breastfeeding in severe phenotypes highlights the importance of individualized assessment and proactive feeding plans.
Across all ages, chronically restricted protein intake places individuals with UCDs at risk for micronutrient deficiencies, supporting routine monitoring and supplementation. Effective long-term management also relies on anticipatory nutrition planning to minimize catabolic risk during illness, procedures, special circumstances (e.g., religious fasting), or other periods of metabolic stress.
Establish Nutrition Prescriptions for Energy and Protein Intakes
1. Individualize energy and protein goals based on age, disease severity, growth, and clinical status. See TABLE #1, Total Protein and Energy Recommendations for Individuals with Urea Cycle Disorders When Well
2. Prescribe the highest protein goal an individual can tolerate, generally 0.8-1.5 g/kg/day.
3. Individuals with mild UCDs typically tolerate a protein-controlled diet1 or an unrestricted protein diet.
1 Protein-controlled diet: a diet that provides at least the DRI from intact protein but does not allow for unrestricted amounts of protein and may or may not include EAA-based medical food.
| Insufficient Evidence | Consensus | Weak | Fair | Strong |
| Conditional | Imperative |
Protein Source
1. In severe UCD, use EAA-based medical food to meet approximately 50% of total protein needs and titrate up or down as clinically indicated. See TABLE #1, Total Protein and Energy Recommendations for Individuals with Urea Cycle Disorders When Well.
2. In mild UCD, use of EAA-based medical food is generally not required to maintain metabolic stability.
3. In individuals with ARG, provide approximately 50% of total protein as intact protein and titrate based on plasma arginine concentrations, proportionately adjusting EAA-based medical food as needed.
4. For individuals who failed a trial of EAA-based medical food and who exhibit low plasma EAAs, consider strategic introduction of up to 50% of the total protein goal from high biological value protein sources.
| Insufficient Evidence | Consensus | Weak | Fair | Strong |
| Conditional | Imperative |
For infants with UCD, use human milk as a source of intact protein when possible.
1. For infants with mild or severe UCD, use human milk, if available, as a sole or primary protein source with close monitoring of intake and lactation support.
2. For infants with severe UCD, consider using expressed human milk to ensure protein goals are consistently met.
3. Provide recommendations for use of supplemental standard infant formula and/or protein-free formula when needed.
| Insufficient Evidence | Consensus | Weak | Fair | Strong |
| Conditional | Imperative |
Use tube feedings when appropriate for supplemental intake of nutrients, fluid, or to administer medications.
1. Consider long-term enteral feeding support in individuals with severe UCDs who experience persistent poor oral intake, particularly during early childhood, or when enteral access is needed to ensure consistent delivery of medications.
2. Refer individuals requiring enteral feeding to feeding specialist(s) for behavioral feeding support and oral skill development.
| Insufficient Evidence | Consensus | Weak | Fair | Strong |
| Conditional | Imperative |
Meet the age-appropriate DRI for intake of fluids, vitamins, and minerals and consider supplementation when insufficient intake is determined.
1. Regularly assess intake of micronutrients (e.g., calcium, copper, iron, selenium, vitamins B12 and D, and zinc) and essential fatty acids. Provide micronutrient or conditionally essential nutrient supplementation as needed based on dietary assessment and biochemical results.
2. Ensure adequate fluid intake (e.g., at least 1.5 ml/kg/day for infants and 1.0 ml/kg/day for older children).
| Insufficient Evidence | Consensus | Weak | Fair | Strong |
| Conditional | Imperative |
Consider additional precautions for planned procedures requiring anesthesia and/or prolonged fasting.
1. Coordinate scheduling of planned procedures as the first case of the day, and arrange admission the day prior to the procedure for appropriate monitoring and management.
2. Minimize fasting (i.e., NPO period) to the shortest duration for surgical safety and administer continuous IV dextrose at an age-appropriate glucose infusion rate, maintained throughout the procedure to prevent catabolism and hyperammonemia.
3. Avoid prolonged fasting, such as religious fasting and fasting during strenuous physical activity.
| Insufficient Evidence | Consensus | Weak | Fair | Strong |
| Conditional | Imperative |